Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Phoenix Molecular Designs

Headquarters: Vancouver, BC, Canada
Year Founded: 2012
Status: Private

BioCentury | Feb 22, 2019
Targets & Mechanisms

Expansion into TNBC

How RNA-binding small molecules could sensitize TNBC to targeted therapies
BioCentury | Feb 8, 2019
Product R&D

Reducing R(i)SK in TNBC

Phoenix aims to make RSK2 the first positive marker to stratify TNBC patients
BioCentury | Jan 18, 2019
Company News

Phoenix, Roche partner to develop TNBC biomarker

BioCentury | Jan 17, 2019
Company News

Phoenix, Roche partner to develop TNBC biomarker

BioCentury | Jul 17, 2017
Company News

Management tracks

Items per page:
1 - 8 of 8